EurDose We demonstrate a rare clinical entity that can easily be cured after correct diagnosis and appropiate treatment. Case retort A 54year-old man complained of night blindness for three weeks. For a period of twenty yemars he had been suffering from chronic pancreatitis with secondary diabetes mellitus, and had been treated with insulin and oral pancreatic enzymes. Due to renal failure, continuous ambulatory peritoneal dialysis (CAPD) was done for one year. Liver function was normrd. B Confirming the diagnosis of night blindness in our patient, the scotopic response in his electroretinogram (ERG) was distinctly reduced while the photopic response was normal. When his blood was examined for a low level of vitamin A as a possible cause for night blindness, we found the value to be reduced below normal (17 pg/dl versus 25-70 pg/dl in normal subjects). Treatment with vitamin A supplement resulted in prompt normalization of vitamin A level (79 pg/dl after two weeks). Symptoms completely disappeared, and the scotopic response in the ERG rehuned to normal. Conclusion Night blindness due to vitamin A deficiency may occur in patients suffering from pancreatic insufficiency even when pancreatic enzymes are substihtted. This therapy does not prevent from deficiency of fat-soluble vitamins (A, D, E, K) in some case. Therefore in patients with acquired night blindness and normal nutrition, the ophthalmologist should consider a malabsorption syndrome with subsequent vitamin A deficiency. In those patients supplementation with vitamin A will restore night vision. Purpose Ubiquitin (Ub) is a member of the stress protein family and has been shown to be particularly active in the degradation of abnonal proteins which form during stress conditions. We document the presence of ubiquitin in the human retina and present its immunohistologic distribution in various disease processes. Mefhcds We have studied 27 human retinae from enucleated eyes embedded in paraffin. The specimens comprised 16 cases with melanoma, 7 with endsta e glaucoma, 2 with macular degeneration, 1 with sympathetic o hthalmia, an B 1 exenteration with an age range between 40 and 90 years. P he hssue was fixed in 4% formaldehyde and processed for paraffin histology. Immunohistochemisby was carried out with an antibody (Ab) against Ub (polyclonal Ab, Accurate chemical [dilution l:l, 2 hours]) and in some specimens with an Ab against Ub conjugating enzyme (E2, pofyclonal Ab, gift from Dr. Banejee, dilution 1:250. overnight). lmmunoreactivity (IR) was tested using the avidinbiotin method, and antibody binding was visualized using either diaminobenzidine (DAB) or aminoethylcarbazole (AEC) as chromogen. Results In most specimens Ub was present throughout the retina but IR was particularly prominent in ganglion cells, in the retinal pigment epithefium (RPE) and in a patchy fashion in the ciliary epithelium. The most intriguing finding was the presence of ubi such as drusen an 3 uitin in sub-pigment epithelial deposits related to aging BLD while reactive changes overlyin tumours were mostly negative. The intensity of immunolabeling of the R B E appeared to increase with age, but otherwise no specific pattern of Ub IR could be identified in the various diseases included in this study. The ubiquitin conjugating enzyme (E2) was demonstrated in the RPE in all sections examined and with some variation also in photoreceptors and the remaining inner retina. In those structures, there was a tendency for anti-E2 to colocalize with Ub. As expected, however, we failed to demonstrate a significant E2 activity in drusen or BLD-like structures. Commenf Ubiquitin appears to be an important substrate in ganglion cells and also in the degradation process and subsequent disposal of proteins from the RPE. Using cur method, no obvious difference in immunohistcchemical lxalization was apparent between eyes with different diseases. 
